Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Aristada cost without insurance?How long has eliquis been out?Chlorhexidine gluconate wipes market analysis?Is there a generic version of januvia?Naltrexone price walmart?
See the DrugPatentWatch profile for Trelegy
Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) was first approved by the FDA on September 18, 2017 [1].
The initial approval date refers to the product’s first FDA approval. After approval, Trelegy’s label has been updated over time for additional uses and/or refinements to dosing and patient selection, but those are later “supplement” approvals rather than the original approval date [1].
DrugPatentWatch tracks FDA drug-approval history, including approval dates, for branded products like Trelegy Ellipta [1].
[1] https://www.drugpatentwatch.com/ (search “Trelegy Ellipta approval date”)
Other Questions About Trelegy :